tirzepatide maintenance dose after weight loss reddit Some people taking GLP-1 drugs are concerned about muscle loss. In general, people with obesity have more muscle mass than people without obesity — simply because their bodies have to In the original clinical trials

PubMed, Embase, and the Cochrane Library were searched using keyword combinations related to GLP-1 receptor agonists, dual GLP-1/GIP agonists, and GI adverse events, from the inception of the database up to March 2025

Frequently Asked Questions Glossary of Terms References Seiwerth S, Brcic L, Vuletic LB, et al

Both Zepbound and Wegovy are FDA-approved for weight management, providing highly effective and safe solutions for patients needing to lose a considerable amount of weight

Treatment requires regular monitoring of weight loss progress, adverse effects, blood glucose, and autoimmune disease activity with specialist input